New and Investigational Antiretroviral Drugs
Resource (Conference Presentation) updated 09/14/2023
Resource (Conference Presentation) updated 09/14/2023
Resource (Conference Presentation) updated 09/14/2023
Resource (Conference Presentation) updated 09/14/2023
Resource (Conference Presentation) updated 09/14/2023
Resource from the RWHAP Best Practices Compilation updated on 02/12/2024
Resource from the RWHAP Best Practices Compilation updated on 01/07/2024
Resource from the RWHAP Best Practices Compilation updated on 04/18/2024
Resource from the RWHAP Best Practices Compilation updated on 01/07/2024
Resource updated 01/31/2023
Resource from the RWHAP Best Practices Compilation updated on 01/03/2024
Resource from the RWHAP Best Practices Compilation updated on 04/01/2024
Resource from the RWHAP Best Practices Compilation updated on 02/20/2024
Resource updated 04/07/2023
Resource updated 06/13/2023
Resource updated 10/09/2023
Resource updated 06/13/2023
Resource (Conference Presentation) updated 09/14/2023
Barriers and facilitators to HCV treatment during the DAA era for the understudied and high-risk population of HIV/HCV co-infected patients who delay or do not consent to treatment, and interventions for increasing DAA treatment uptake.
Resource (Conference Presentation) updated 09/14/2023
Review of a process to develop community-informed social media initiatives promoting RWHAP services, engagement in care, and U=U, scalable to any (or no) budget.
Resource (Conference Presentation) updated 09/14/2023
Review of the Greater Than AIDS Atlanta campaign to reach priority populations with HIV information and resources through social media to improve EHE outcomes.
Resource (Conference Presentation) updated 09/14/2023